MB-CART2019.1 Clinical Trials

2 actively recruiting trials

Also known as: Anti-CD20/CD19 CAR T cells, CD20/CD19-targeting CAR T cells

Filter by location:

Other2 trials

DALY II Japan/MB-CART2019.1 for DLBCL

Phase 2

Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.